Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind

Li B, Yan J, Pu J, Tang J, Xu S, Wang X. Esophageal dysfunction in systemic sclerosis: an update. Rheumatol Ther. 2021;8:1535–49.

Article  Google Scholar 

Snyder DL, Crowell MD, Kahn A, Griffing WL, Umar S, Ramirez FC. Prevalence of Barrett’s esophagus in female patients with scleroderma. Am J Gastroenterol. 2021;116:517–21.

Article  Google Scholar 

Kahan A, Bour B, Couturier D, Amor B, Menkes CJ. Nifedipine and esophageal dysfunction in progressive systemic sclerosis. A controlled manometric study. Arthritis Rheum. 1985;28:490–5.

CAS  Article  Google Scholar 

Kowal-Bielecka O, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76:1327–39.

Article  Google Scholar 

Kadakuntla A, Juneja A, Sattler S, et al. Dysphagia, reflux and related sequelae due to altered physiology in scleroderma. World J Gastroenterol. 2021;27:5201–18.

CAS  Article  Google Scholar 

Biswas Roy S, Banks P, Kunz M, et al. Prevalence and natural history of Barrett’s esophagus in lung transplant: a single-center experience. Ann Thorac Surg. 2019;107:1017–23.

Article  Google Scholar 

Hughes J, Lockhart J, Joyce A. Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain? Br J Clin Pharmacol. 2007;64:83–9.

CAS  Article  Google Scholar 

Jean F, Aubert A, Bloch F, et al. Effects of diltiazem versus nifedipine on lower esophageal sphincter pressure in patients with progressive systemic sclerosis. Arthritis Rheum. 1986;29:1054–5.

CAS  Article  Google Scholar 

Kim HS, Conklin JL, Park H. The effect of sildenafil on segmental oesophageal motility and gastro-oesophageal reflux. Aliment Pharmacol Ther. 2006;24:1029–36.

CAS  Article  Google Scholar 

Lee TH, Lee JS, Hong SJ, et al. Examination of the effects of vardenafil on esophageal function using multichannel intraluminal impedance and manometry. J Neurogastroenterol Motil. 2012;18:399–405.

Article  Google Scholar 

Kikendall JW, Mellow MH. Effect of sublingual nitroglycerin and long-acting nitrate preparations on esophageal motility. Gastroenterology. 1980;79:703–6.

CAS  Article  Google Scholar 

Tutuian R, Castell DO. Esophageal motility disorders (distal esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter): modern management. Curr Treat Options Gastroenterol. 2006;9:283–94.

Article  Google Scholar 

Wei A, Gu Z, Li J, et al. Clinical adverse effects of endothelin receptor antagonists: insights from the meta-analysis of 4894 patients from 24 randomized double-blind placebo-controlled clinical trials. J Am Heart Assoc. 2016;5: e003896.

Article  Google Scholar 

Parfitt JR, Jayakumar S, Driman DK. Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol. 2008;32:1367–72.

Article  Google Scholar 

Kim JJ, Mulki RH, Sebastian KM. Recalcitrant esophageal stricture secondary to mycophenolate mofetil. Case Rep Gastrointest Med. 2020;2020:8817801.

PubMed  PubMed Central  Google Scholar 

Nguyen T, Park JY, Scudiere JR, Montgomery E. Mycophenolic acid (CellCept and Myfortic) induced injury of the upper GI tract. Am J Surg Pathol. 2009;33:1355–63.

Article  Google Scholar 

Matsuda R, Yamamichi N, Shimamoto T, et al. Gastroesophageal reflux disease-related disorders of systemic sclerosis based on the analysis of 66 patients. Digestion. 2018;98:201–8.

CAS  Article  Google Scholar 

Seminerio J, McGrath K, Arnold CA, et al. Medication-associated lesions of the GI tract. Gastrointest Endosc. 2014;79:140–50.

Article  Google Scholar 

Lazenby JP, Guzzo MR, Harding SM, et al. Oral corticosteroids increase esophageal acid contact times in patients with stable asthma. Chest. 2002;121:625–34.

CAS  Article  Google Scholar 

Bigard MA, Pelletier AL. Esophageal complications of non-steroidal antiinflammatory drugs. Gastroenterol Clin Biol. 2004;28(3):58–61.

Article  Google Scholar 

Avidan B, Sonnenberg A, Schnell TG, Budiman-Mak E, Sontag SJ. Risk factors of oesophagitis in arthritic patients. Eur J Gastroenterol Hepatol. 2001;13:1095–9.

CAS  Article  Google Scholar 

de Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335:1016–21.

Article  Google Scholar 

Martín-Merino E, Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S. Depression and treatment with antidepressants are associated with the development of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2010;31:1132–40.

PubMed  Google Scholar 

Brahm NC, Kelly-Rehm MC. Antidepressant-mediated gastroesophageal reflux disease. Consult Pharm. 2011;26:274–8.

Article  Google Scholar 

Rushnak MJ, Leevy CM. Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study. Am J Gastroenterol. 1980;73:127–30.

CAS  PubMed  Google Scholar 

Jung HK, Choung RS, Talley NJ. Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications. J Neurogastroenterol Motil. 2010;16:22–9.

Article  Google Scholar 

留言 (0)

沒有登入
gif